Lucidenic acid B

• Description:

  Lucidenic acid B (Lucidenicacid B), a natural compound extracted from Ganoderma lucidum, induces activation of caspase-9 and caspase-3 and cleavage of PARP, which can induce apoptosis in human leukemia cells through mitochondrial mediation. Lucidenic acid B inhibits PMA-induced invasion of human hepatocellular carcinoma cells by inactivating the MAPK/ERK signaling pathway and decreasing the binding activity of NF-kappaB and AP-1. Lucidenic acid B had no effect on cell cycle and necrotic cells.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  474.59

• Molecular Formula:

  C27H38O7

• Notes:

  Research use only, not for human use.

• Receptor:

  Caspase | Apoptosis

• CAS Number:

  95311-95-8